Inventor
George V. DeLucca
Inventor
Wilmington, DE, US
Overview
Patents· 39 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds48%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
A61KPreparations for medical, dental or toiletry purposes17%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
C07CAcyclic or carbocyclic compounds4%
C07BGeneral methods of organic chemistry2%
C07KPeptides2%
C04BLime, magnesia1%
PatentTitleYear
10,112,941Tricyclic compounds as anticancer agents201810,106,559Substituted tetrahydrocarbazole and carbazole carboxamide compounds20189,751,879'Tricyclic compounds as anticancer agents'20179,725,449'Tricyclic compounds as anticancer agents'20179,714,234'Carbazole carboxamide compounds'20179,492,460'Carbazole compounds useful as bromodomain inhibitors'20169,458,156'Tricyclic compounds as anticancer agents'20169,334,290'Substituted tetrahydrocarbazole and carbazole carboxamide compounds'20169,273,014'Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof'20169,242,941'Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds'20169,133,139'Fluoroalkyl-1,4-benzodiazepinone compounds'20158,999,918'Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof'20158,685,969'Carboline carboxamide compounds useful as kinase inhibitors'20148,362,065'Carbazole carboxamide compounds useful as kinase inhibitors'20138,084,620'Carbazole carboxamide compounds useful as kinase inhibitors'20117,550,486'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity'20097,514,430'Piperizinones as modulators of chemokine receptor activity'20097,351,720'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity'20087,312,222'Heterocyclic piperidines as modulators of chemokine receptor activity'20077,291,744'N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity'20076,974,869'Piperizinones as modulators of chemokine receptor activity'20056,919,368'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity'20056,906,066'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity'20056,897,234'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity'20056,875,776'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity'20056,780,857'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity'20046,759,411'Heterocyclic piperidines as modulators of chemokine receptor activity'20046,706,735'2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity'20046,605,623'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity'20036,525,069'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity'20036,521,592'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity'20036,492,400'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity'20026,486,180'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity'20026,444,686'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity'20026,441,001'2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity'20026,331,541'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity'20016,331,545'Heterocycyclic piperidines as modulators of chemokine receptor activity'20016,313,110'Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor'20015,763,469'Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2009Based in Wilmington, DE, US· patent location history
2002–2009Patents assigned to BRISTOL MYERS SQUIBB PHARMA CO (16)· patent assignee history
2005–2018Based in Pennington, NJ, US· patent location history
2007–2018Patents assigned to BRISTOL MYERS SQUIBB CO (18)· patent assignee history
2011–2014Patents assigned to BATT DOUGLAS G (3)· patent assignee history
2011–2014Patents assigned to DELUCCA GEORGE V (3)· patent assignee history
2011–2014Patents assigned to LIU QINGJIE (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 18 | 2007–2018 |
| BRISTOL MYERS SQUIBB PHARMA CO | 16 | 2002–2009 |
| BATT DOUGLAS G | 3 | 2011–2014 |
| DELUCCA GEORGE Vself | 3 | 2011–2014 |
| LIU QINGJIE | 3 | 2011–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Wilmington, Delaware, US | 20 | 1998–2009 |
| Pennington, New Jersey, US | 19 | 2005–2018 |